Myocardial T1 mapping: where are we now and where are we going?
暂无分享,去创建一个
[1] C. Wanner,et al. Fabry disease and the heart. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[2] U. Sechtem,et al. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. , 2014, European heart journal cardiovascular Imaging.
[3] Andrew J Taylor,et al. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. , 2014, Heart rhythm.
[4] J. Townend,et al. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. , 2014, JACC. Cardiovascular imaging.
[5] Richard B Thompson,et al. Saturation recovery single‐shot acquisition (SASHA) for myocardial T1 mapping , 2014, Magnetic resonance in medicine.
[6] M. Robson,et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.
[7] Richard B. Thompson,et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. , 2014, Radiology.
[8] L. Kuller,et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. , 2014, European heart journal.
[9] D. Stub,et al. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. , 2014, Journal of the American College of Cardiology.
[10] S. K. White,et al. Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.
[11] L. Brunereau,et al. Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience , 2014, Journal of Cardiovascular Magnetic Resonance.
[12] J. Moon,et al. Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study , 2014, Journal of Cardiovascular Magnetic Resonance.
[13] J. Moon,et al. Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues , 2014, Current Cardiovascular Imaging Reports.
[14] P. Kellman,et al. T1-mapping in the heart: accuracy and precision , 2014, Journal of Cardiovascular Magnetic Resonance.
[15] B. Prendergast,et al. Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations , 2013, BMJ Open.
[16] G. Maurer,et al. Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.
[17] C. Jellis,et al. Myocardial T1 mapping: modalities and clinical applications. , 2013, Cardiovascular diagnosis and therapy.
[18] M. Robson,et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.
[19] Stefan Neubauer,et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.
[20] Tobias Schaeffter,et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study , 2013, Journal of Cardiovascular Magnetic Resonance.
[21] M. Friedrich,et al. Cardiac Magnetic Resonance Assessment of Myocarditis , 2013, Circulation. Cardiovascular imaging.
[22] Stefan L. Zimmerman,et al. Cardiac magnetic resonance T1 mapping of left atrial myocardium. , 2013, Heart rhythm.
[23] Sung Ho Hwang,et al. Diagnosis of Acute Global Myocarditis Using Cardiac MRI with Quantitative T1 and T2 Mapping: Case Report and Literature Review , 2013, Korean journal of radiology.
[24] L. Ling,et al. Diffuse Ventricular Fibrosis Is a Late Outcome of Tachycardia-Mediated Cardiomyopathy After Successful Ablation , 2013, Circulation. Arrhythmia and electrophysiology.
[25] D. Bluemke,et al. Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners , 2013, Journal of Cardiovascular Magnetic Resonance.
[26] Harry Rakowski,et al. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. , 2013, JACC. Cardiovascular imaging.
[27] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.
[28] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[29] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[30] E. Nagel,et al. Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.
[31] S. K. White,et al. Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease , 2013, Journal of Cardiovascular Magnetic Resonance.
[32] Andrew S Flett,et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.
[33] S. K. White,et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.
[34] A. Flett,et al. Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.
[35] L. Ling,et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. , 2012, Journal of the American College of Cardiology.
[36] M. Dweck,et al. Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.
[37] A. Taylor,et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. , 2012, European heart journal cardiovascular Imaging.
[38] G. Faggian,et al. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. , 2012, The Journal of thoracic and cardiovascular surgery.
[39] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[40] P. Kellman,et al. Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.
[41] Steffen Ringgaard,et al. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.
[42] E. Cassinerio,et al. An update on iron chelation therapy. , 2012, Blood transfusion = Trasfusione del sangue.
[43] M. Robson,et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.
[44] C. Kramer,et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.
[45] S. Plein,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.
[46] W. Kim,et al. Mass Reduction and Functional Improvement of the Left Ventricle after Aortic Valve Replacement for Degenerative Aortic Stenosis , 2011, The Korean journal of thoracic and cardiovascular surgery.
[47] C. Kramer,et al. Cardiovascular Magnetic Resonance Applications in Daily Practice , 2011 .
[48] O. Simonetti,et al. Direct T2 quantification of myocardial edema in acute ischemic injury. , 2011, JACC. Cardiovascular imaging.
[49] Pierre Croisille,et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.
[50] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[51] M. Beer,et al. Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis , 2009, Circulation.
[52] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[53] Matthew W. Darlison,et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[54] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[55] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[56] S. Nattel,et al. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[57] Andreas Greiser,et al. Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.
[58] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[59] S. Neubauer,et al. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging. , 2006, International journal of cardiology.
[60] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .
[61] David M Higgins,et al. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study. , 2006, Radiology.
[62] L. Brown. Cardiac extracellular matrix: a dynamic entity. , 2005, American journal of physiology. Heart and circulatory physiology.
[63] R. Falk,et al. Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.
[64] David M Higgins,et al. Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.
[65] Dudley J Pennell,et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[66] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.
[67] Heiko Mahrholdt,et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[68] M. Russo,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.
[69] S. Neubauer,et al. The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies , 2012, Current Cardiology Reports.
[70] P. Elliott,et al. Anderson-Fabry disease and the heart. , 2010, Progress in cardiovascular diseases.
[71] O. Vignaux. Cardiac sarcoidosis: spectrum of MRI features. , 2005, AJR. American journal of roentgenology.